Description
Gejlid-30 contains Gliclazide 30mg Modified Release, a sulfonylurea antidiabetic agent indicated for the management of Type 2 diabetes mellitus, as prescribed by a healthcare professional.
Composition:
Gliclazide 30mg Modified Release
Pack Size:
10×10 Tablets
Packing:
Blister
Therapeutic Segment:
Diabetology | Cardio-Diabetic Care
Key Benefits:
• Helps improve glycaemic control in Type 2 diabetes mellitus
• Supports effective blood glucose management throughout the day
• Modified-release formulation for sustained drug delivery
• To be used only under medical supervision
• Convenient oral tablet formulation
Packaging:
10×10 Blister Pack
Reviews
There are no reviews yet.